Intratumoral Microdosing of Motolimod in HNSCC

NCT04272333 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Partner Termination

Conditions

HNSCC

Interventions

DRUG: Motolimod
BIOLOGICAL: Nivolumab
COMBINATION_PRODUCT: Motolimod + Nivolumab

Sponsor

Presage Biosciences

Collaborators

[object Object]
[object Object]